Sheree Blankenship
Women's Health · Smithfield, NCNPI 1841534609
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $693 of the $787 with a category attached, or 88.1%. It is spread thinly across 17 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations.
Across 35 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$173
- Coopersurgical, Inc.$110
- Organon$93
- Exeltis, USA Inc.$91
- Bayer$37
- Sage Therapeutics, LLC$36
- plus $246 from 11 others
What the payments were for
- Food & beverage$69388%
- Education$9412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 5 | $173 |
| Coopersurgical, Inc. | 5 | $110 |
| Organon | 4 | $93 |
| Exeltis, USA Inc. | 5 | $91 |
| Bayer | 2 | $37 |
| Sage Therapeutics, LLC | 2 | $36 |
| Irhythm Technologies, Inc. | 1 | $32 |
| Aspira Women's Health Inc | 2 | $32 |
| Biogen | 1 | $26 |
| Amgen | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Shield Therapeutics Inc | 1 | $23 |
| Novo Nordisk | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Pfizer | 1 | $16 |
| Millicent US Inc | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $15 |
How this compares
$787 in reported general payments places this provider in the 70th percentile of 158 women's health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $1,604 |
| Medroxyprogesterone Acetate | 14 | $708 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $248 |
| Fluconazole | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Other women's health in Smithfield
- Meredith HarrisRaleigh$241K
- Jami ChrzanowskiGreensboro$27K
- Amy KemmerlinCharlotte$8K
- Kylie CajkaCharlotte$5K
- Lindsey MosleyCharlotte$5K
- Lanika WrightGreenville$3K
- Melinda DavesHickory$3K
- Margaret DarstRaleigh$3K
- Kristin AllisonRaleigh$3K
- Tiffany MoonPlymouth$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.